Clinical Trial Update: Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia [Phase 2, Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 2/Phase 3 clinical trial evaluating oxcarbazepine as an adjunct to antipsychotic therapy in acute schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Oxcarbazepine (Oxcarbazepine)

Snippet

Sponsor: University of Cologne | Conditions: Schizophrenia | Phase 2, Phase 3 | Status: COMPLETED